WARFARIN TIME IN THERAPEUTIC RANGE TRAJECTORIES IN POTENTIAL SWITCHERS TO DIRECT ORAL ANTICOAGULANTS

被引：0
|
作者：
Pundi, Krishna [1 ]
Perino, Alexander [1 ]
Fan, Jun [1 ]
Schmitt, Susan [1 ]
Kothari, Mitra [1 ]
Szummer, Karolina [1 ]
Askari, Mariam [1 ]
Heidenreich, Paul A. [1 ]
Turakhia, Mintu [1 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2020年 / 75卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1273-247
引用
收藏
页码：416 / 416
页数：1
相关论文
共 50 条
  • [1] Changes in Time in Therapeutic Range Within a Warfarin Anticoagulation Clinic Following Introduction of Direct Oral Anticoagulants
    Samuel, Preethi
    Cassidy, Kaitlyn
    Lazarevskiy, Pauletta
    Cope, Rebecca
    JOURNAL OF PHARMACY PRACTICE, 2024, 37 (06) : 1311 - 1317
  • [2] Reduced Dose Direct Oral Anticoagulants Compared to Warfarin With High Time in Therapeutic Range in Nonvalvular Atrial Fibrillation
    Jansson, Martin
    Sjogren, Vilhelm
    Sjalander, Sara
    Bjorck, Fredrik
    Renlund, Henrik
    Norrving, Bo
    Sjalander, Anders
    CIRCULATION, 2019, 140
  • [3] Time-in-therapeutic-range defined warfarin and direct oral anticoagulants in atrial fibrillation: a Nationwide Cohort Study
    Lehto, Mika
    Luojus, Alex
    Halminen, Olli
    Haukka, Jari
    Putaala, Jukka
    Linna, Miika
    Mustonen, Pirjo
    Kinnunen, Janne
    Lehtonen, Ossi
    Teppo, Konsta
    Tiili, Paula
    Kouki, Elis
    Itainen-Stromberg, Saga
    Niemi, Mikko
    Aro, Aapo L.
    Hartikainen, Juha
    Airaksinen, K. E. Juhani
    ANNALS OF MEDICINE, 2024, 56 (01)
  • [4] Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation
    Jansson, M.
    Sjalander, S.
    Sjogren, V
    Bjorck, F.
    Renlund, H.
    Norrving, B.
    Sjalander, A.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 55 (03) : 415 - 425
  • [5] Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation
    M. Jansson
    S. Själander
    V. Sjögren
    F. Björck
    H. Renlund
    B. Norrving
    A. Själander
    Journal of Thrombosis and Thrombolysis, 2023, 55 : 415 - 425
  • [6] Meta-Analysis of Safety and Efficacy of Direct Oral Anticoagulants Versus Warfarin According to Time in Therapeutic Range in Atrial Fibrillation
    Lee, Joseph J.
    Ha, Andrew C. T.
    Dorian, Paul
    Verma, Maya
    Goodman, Shaun G.
    Friedrich, Jan O.
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 140 : 62 - 68
  • [7] Direct oral anticoagulants or warfarin for A fib?
    Lyon, Corey
    Reed, Alex
    Prasad, Shailendra
    JOURNAL OF FAMILY PRACTICE, 2017, 66 (08): : 510 - 512
  • [8] THERAPEUTIC RANGE OF ORAL ANTICOAGULANTS
    INAUEN, W
    BOMBELI, T
    BAUMGARTNER, HR
    HAEBERLI, A
    STRAUB, PW
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1987, : 10 - 10
  • [9] Direct Oral Anticoagulants Versus Warfarin for Atrial Fibrillation in Relation to Time in Therapeutic Range: An Analysis of US Food and Drug Administration Regulatory Data
    Boesen, Kim
    Saiz, Luis Carlos
    Gotzsche, Peter C.
    Erviti, Juan
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2025, 18 (03):
  • [10] Cost of warfarin versus direct oral anticoagulants
    Mannarino, Marco G.
    CANADIAN FAMILY PHYSICIAN, 2020, 66 (01) : 9 - 9
12345